A B S T R A C T
A pathological feature in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC). Oxidized low-density lipoprotein (LDL), known to accumulate in the atherosclerotic arterial walls, impairs endothelium-dependent relaxation and causes EC apoptosis. A major bioactive ingredient of the oxidized LDL is lysophosphatidylcholine (LPC), which at higher concentrations causes apoptosis and necrosis in various EC. There is hitherto no report on LPC-induced cytotoxicity in brain EC. In this work, we found that LPC caused cytosolic Ca 2+ overload, mitochondrial membrane potential decrease, p38 activation, caspase 3 activation and eventually apoptotic death in mouse cerebral bEND.3 EC. In contrast to reported reactive oxygen species (ROS) generation by LPC in other EC, LPC did not trigger ROS formation in bEND.3 cells. Pharmacological inhibition of p38 alleviated LPC-inflicted cell death. We examined whether heparin could be cytoprotective: although it could not suppress LPC-triggered Ca 2+ signal, p38 activation and mitochondrial membrane potential drop, it did suppress LPC-induced caspase 3 activation and alleviate LPC-inflicted cytotoxicity. Our data suggest LPC apoptotic death mechanisms in bEND.3 might involve mitochondrial membrane potential decrease and p38 activation. Heparin is protective against LPC cytotoxicity and might intervene steps between mitochondrial membrane potential drop/p38 activation and caspase 3 activation.
I N T R O D U C T I O N
One of the pathological manifestations in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC) [1] . A number of pro-atherogenic factors, such as oxidized low-density lipoproteins (LDLs), angiotensin II and oxidative stress, could cause EC dysfunction and apoptosis [2] . Oxidized LDL, known to be accumulated in the atherosclerotic arterial walls, is suggested to contribute to the impairment of endothelium-dependent relaxation (EDR) of the underlying smooth muscle cells. A convincing evidence comes from the observation that when normal arteries are challenged with oxidized LDL, phenylephrine (PE)-induced contraction remains unaffected, while acetylcholine (ACh)-triggered EDR (but not nitroglycerin-triggered endothelium-independent relaxation) is strongly inhibited [3] . In addition to EC dysfunction, oxidized LDL could also cause EC apoptosis, which is widely reported in earlier literature [4] . Reports on the impact of oxidized LDL on brain EC death remain relatively scarce. In one such report, oxidized LDL was shown to trigger mouse cerebral EC apoptosis in a Bax-mitochondria-caspase-dependent manner [5] ; such apoptosis could be protected by resveratrol [6] .
A major bioactive ingredient of the oxidized LDL appears to be lysophosphatidylcholine (LPC), as this lysolipid could mimic oxidized LDL in inhibiting EDR, and LPC-depleted oxidized LDL becomes much less effective in inhibiting EDR [3] . A mechanism by which LPC causes an impairment of EDR is the inhibition of the production/release from the endothelium of endotheliumderived relaxing factor and endothelium-derived hyperpolarizing factor, which is dependent upon the cytosolic Ca 2+ concentration ([Ca   2+ ]i) [7] . There are several lines of evidence to suggest LPC involvement in the inhibition of Ca 2+ signaling, inositol 1,4,5-trisphosphate (lnsP 3 ) generation in bovine aortic EC [7] , activation of protein kinase C in human umbilical vein EC (HUVEC) [8] and receptor-G protein uncoupling in porcine aortic EC [1] and inhibition of agonist-triggered Ca 2+ release [9] .
Lysophosphatidylcholine at higher concentrations cause cytotoxic changes, such as morphological distortion and leakage of intracellularly loaded dye (fura-2) in bovine aortic EC [7] . LPC has been shown to cause apoptosis in HUVEC by sensitizing Fas receptor by means of down regulating FLICE-inhibitory protein, a caspase inhibitor [10] . LPC increases cytosolic Ca 2+ and reactive oxygen species (ROS); and antioxidants and Ca 2+ antagonists could prevent LPC-induced necrosis in mouse aortic EC [11] . Likewise, in HUVEC, LPC causes apoptosis, generation of ROS and caspase-3 activation, which could be inhibited by antioxidants and superoxide dismutase [12] . There is hitherto no report on LPC-induced cytotoxicity in brain EC. In this work, we examined the cytotoxicity of LPC in mouse cerebral microvascular bEND.3 cells and the protective effects of heparin.
M A T E R I A L S A N D M E T H O D S
Materials and cell culture Dulbecco's modified Eagle's medium (DMEM), fetal calf serum and tissue culture reagents were purchased from Invitrogen Corporation (Carlsbad, CA, USA). LPC, cyclopiazonic acid (CPA), heparin, simvastatin, SB203580 and parthenolide were from Sigma-Aldrich (Darmstadt, Germany). Fura-2 AM was purchased from Calbiochem-Millipore (Darmstadt, Germany). bEND.3 cells were cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.
Assay of cell viability and apoptosis
Cell viability was examined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. Cells were cultured in a 96-well plate at a density of 1.5 9 10 4 per well and were then treated with DMSO, LPC or LPC plus other drugs for 18 h. MTT (final concentration at 0.5 mg/mL) was subsequently added to each well and then further incubated for 4 h. The culture medium was then removed and 100 lL of DMSO was added to each well for 15 min (with shaking) to dissolve the cells. The absorbance at 595 nm was measured using an ELISA reader and was used as an indicator of cell viability. Apoptosis was assessed by the TUNEL method using a kit from Roche (Basel, Switzerland), according to the manufacturer's instructions.
Microfluorimetric measurement of cytosolic Ca

2+
Microfluorimetric measurement of cytosolic Ca 2+ concentration was performed using fura-2 as the Ca
-sensitive fluorescent dye as described previously [13] . Briefly, cells were incubated with 5 lM fura-2 AM (Invitrogen) for 1 h at 37°C and then washed in extracellular bath solution which contained (mM): 140 NaCl, was omitted and 100 lM EGTA was supplemented. Cells were pretreated with control solvent or various drugs/ blockers before they were stimulated with LPC. Cells were alternately excited with 340 and 380 nm using an optical filter changer (Lambda 10-2; Sutter Instruments, Novato, CA, USA). Emission was collected at 500 nm and images were captured using a CCD camera (CoolSnap HQ2; Photometrics, Tucson, AZ, USA) linked to an inverted Nikon TE 2000-U (Tokyo, Japan) microscope. Images were analyzed with an MAG Biosystems Software (Exton, PA, USA). All imaging experiments were performed at room temperature (25°C).
Western blot
Western blotting was performed as described previously [14] . Briefly, cells were treated with DMSO, heparin, LPC or LPC plus heparin for the indicated time periods, and then washed in cold phosphate-buffered saline (PBS), lysed for 30 min on ice with radioimmunoprecipitation assay (RIPA) buffer. Protein samples containing 30 lg protein were separated on 10% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE, Biocompare, San Francisco, CA, USA) and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA). The membranes were incubated for 1 h with 5% nonfat milk in PBS buffer to block nonspecific binding. The membranes were incubated with various primary antibodies such as antiactin (1 : 10 000), anti-caspase 3 (1 : 1000), anticleaved caspase 3 (1 : 1000), anti-p38 (1 : 1000), anti-phosphorylated p38 (1 : 1000) (Cell Signaling Technology, Danvers, MA, USA). Subsequently, the membranes were incubated with goat anti-rabbit or goat anti-mouse peroxidase-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 1 h. The blots were visualized by enhanced chemiluminescence (Millipore, Billerica, MA, USA) using Kodak X-OMAT LS film (Eastman Kodak, Rochester, NY, USA). heparin for designated time periods and were then exposed to 5 lM rhodamine-123 for 20 min. Fluorescence was then detected using a SpectraMax M2 multimode plate reader (Molecular Devices, San Jose, CA, USA) with excitation at 485 nm and emission at 538 nm.
Measurement of mitochondrial membrane potential
Measurement of ROS
Cells were incubated with 10 lM DCFDA in FBS-free medium for 45 min at 37°C, then incubated with DMSO, parthenolide (positive control) or LPC for different periods of time and subject to flow cytometry analysis. Excitation and emission wavelengths were set at 495 and 529 nm, respectively.
Statistical analysis
Data are presented as means AE SEM. Unpaired or paired Student's t-test was used for two-group comparisons.
ANOVA was used to compare multiple groups, followed by the Tukey's HSD post hoc test. A value of P < 0.05 was considered to represent a significant difference.
R E S U L T S LPC-elicited cell death and Ca 2+ signaling
We first examined LPC-induced cytotoxicity. As shown in Figure 1a , LPC concentration dependently caused cell death, the half-lethal concentration was approximately 50 lM. To examine whether LPC-inflicted cell death was apoptotic in nature, we used TUNEL (Figure 1b) , which showed that cell death was indeed apoptotic. Close to 90% of LPC-treated cells were apoptotic ( Figure 1c) . Lysophosphatidylcholine has been known to trigger Ca 2+ signals in various EC. As shown in Figure 2a , As shown in Figure 3a , La 3+ slowed down but did not decrease the magnitude of LPC-induced Ca 2+ signal.
Heparin and simvastatin did not significantly suppress LPC-induced Ca 2+ signal (Figure 3b,c) .
LPC-induced apoptotic cell death was alleviated by heparin
We then examined whether La
3+
, heparin and simvastatin could prevent LPC-induced cytotoxicity in bEND.3 cells. Heparin (30 U/mL), but not La 3+ and simvastatin, significantly rescued LPC-inflicted cell death by 28% (Figure 4a ). La 3+ also offered protection although it did not reach statistical significance. Heparin itself caused a very mild (6.6%) increase in cell viability (Figure 4b ). Therefore, heparin had protective effects on LPC cytotoxicity. However, heparin did not inhibit LPC-triggered Ca 2+ signal (Figure 3b ), suggesting heparin protection is unrelated to Ca 2+ influx blockade. We performed TUNEL assay to examine whether heparin could protect against LPCinflicted apoptosis (Figure 4c) . We found that heparin Figure 4a . We next examined whether heparin protected against LPC-induced apoptosis, using cleaved caspase-3 as a apoptotic marker. As shown in Figure 5 , LPC treatment raised the level of cleaved caspase-3, and this was significantly alleviated by heparin.
LPC did not cause ROS generation
Previous works show that LPC cytotoxicity involves ROS generation; superoxide dismutase activities and antioxidants could alleviate LPC cytotoxicity [11, 12, 17, 18] . We examined whether LPC triggered ROS in bEND.3 cells. Rather surprisingly, we found that LPC did not cause ROS formation (parthenolide was used as a positive control) (Figure 6a,b) . Consistently, LPC cytotoxicity was not prevented by the antioxidant ascorbic acid (Figure 6c ). Taken together, the results suggest LPC cytotoxicity in bEND.3 cells did not involve ROS.
LPC-elicited p38 activation and mitochondrial depolarization were not suppressed by heparin Lysophosphatidylcholine has been shown to cause HUVEC cell death by activating p38 [19] . As shown in Figure 7a ,b, LPC activated p38, causing raised level of phosphorylated p38 throughout the 2-h period; however, heparin did not suppress p38 activation by LPC. LPC-inflicted cell death was alleviated by 20.3% by SB203580, a p38 inhibitor (Figure 7c) . However, such alleviation may be partly due to the fact that this drug caused 15.5% increase in cell viability. The effect of LPC on mitochondrial membrane potential was investigated. Results in Figure 8 show that LPC caused mitochondrial depolarization, as indicated by an increase in rhodamine 123 fluorescence. Heparin only caused a mild alleviation of LPC-elicited mitochondrial depolarization, but such alleviation did not reach statistical significance.
D I S C U S S I O N
Hitherto, all of the work on LPC cytotoxic actions on EC has focused on EC other than brain microvascular EC, for example aortic EC and HUVEC. We here provide the first report that LPC caused apoptotic death in bEND.3 cortical microvascular EC. This apoptotic death Heparin protects lysophosphatidylcholine cytotoxicity was preceded by cytosolic Ca 2+ overload (Figure 2 ), p38 activation (Figure 7) , mitochondrial potential decrease ( Figure 8 ) and eventually caspase 3 activation ( Figure 5 ). Our data that p38 activation played a role in LPC-inflicted cell death (bEND.3 cells) were consistent with the finding that LPC-induced HUVEC death also involves p38 [19] . In mouse aortic EC, LPC increases cytosolic Ca 2+ and ROS; and antioxidants and Ca 2+ antagonists could prevent LPC-induced necrosis [11] . In HUVEC, LPC causes apoptosis, generation of ROS and caspase-3 activation, which could be inhibited by antioxidants and superoxide dismutase [12] . In two recent reports, LPC has also been shown to trigger ROS production in HUVEC [20, 21] . However, in this work, LPC did not stimulate ROS formation in bEND.3 cells at all, and LPC-inflicted cell death could not be rescued by ascorbic acid ( Figure 6 ). Heparin is EC-protective and has been shown to reduce atherosclerosis in many studies using animals fed with high cholesterol [23] , yet the molecular mechanisms have not been fully understood. In addition to the block of LPC Ca 2+ elevation and non-selective cation by heparin [16] , an early work shows that heparin could protect EC from xanthine/xanthine oxidase-induced free radical injury [24] . Our findings that heparin could offer protective effect on LPC-inflicted cell death and apoptosis ( Figure 4 ) may not be attributed to its antioxidant effect since LPC cytotoxicity in bEND.3 cells appeared to be unrelated to ROS generation (Figure 6 ). Heparin protective effects could neither be explained by Ca 2+ antagonism, since it did not prevent LPC-triggered Ca 2+ elevation at all. Heparin has been reported to prevent azurocidin-elicited mitochondrial membrane potential decrease in HUVEC [25] . However, heparin alleviation of LPC-elicited mitochondrial membrane potential decrease was mild and did not reach statistical significance in bEND.3 cells (Figure 8 ). Further, p38 activation was not affected by heparin (Figure 7) . Given that heparin did significantly suppress LPC-triggered caspase 3 activation, it may act on a step between mitochondrial membrane potential collapse/ p38 activation and caspase 3 activation. An LPC receptor GPR4 has been known to express in human brain microvascular EC, and its expression increases upon stimulation by tumor necrosis factora (TNFa) and hydrogen peroxide [26] . It was later shown that in human dermal microvascular EC, LPC causes dysregulation of EC barrier function by interacting with GPR4 since silencing GPR4 expression using siRNA alleviate LPC-induced (i) decrease in transendothelial resistance, (ii) stress fiber formation and (iii) activation of RhoA [27] . In addition, in human brain microvascular EC, LPC also stimulates monocytes transmigration across EC barrier by interacting with GPR4 [28] . It is hitherto unknown if GPR4 mediates, directly or indirectly, the known phenomenon of LPC-triggered Ca 2+ elevation, ROS formation, mitochondrial dysfunction, caspase activation and consequent cell death. Further work will be needed to elucidate this. 
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